HCA Healthcare Inc (NYSE:HCA) – Equities research analysts at SunTrust Banks upped their Q3 2020 earnings per share estimates for shares of HCA Healthcare in a research report issued to clients and investors on Tuesday, July 28th. SunTrust Banks analyst D. Macdonald now anticipates that the company will post earnings of $2.32 per share for the quarter, up from their previous forecast of $1.93. SunTrust Banks has a “Buy” rating and a $150.00 price objective on the stock. SunTrust Banks also issued estimates for HCA Healthcare’s Q4 2020 earnings at $3.26 EPS and FY2020 earnings at $11.15 EPS.
HCA Healthcare (NYSE:HCA) last announced its earnings results on Wednesday, July 22nd. The company reported $3.23 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.94) by $4.17. HCA Healthcare had a net margin of 6.67% and a negative return on equity of 589.47%. The company had revenue of $11.07 billion for the quarter, compared to analysts’ expectations of $10.44 billion. During the same period last year, the firm earned $2.21 earnings per share. The business’s revenue for the quarter was down 12.2% on a year-over-year basis.
Several other brokerages have also recently commented on HCA. Zacks Investment Research cut shares of HCA Healthcare from a “hold” rating to a “sell” rating and set a $103.00 target price on the stock. in a report on Tuesday, June 23rd. Mizuho lifted their price objective on shares of HCA Healthcare from $136.00 to $145.00 and gave the company a “buy” rating in a research note on Thursday, July 23rd. Raymond James lifted their price objective on shares of HCA Healthcare from $130.00 to $140.00 and gave the company an “outperform” rating in a research note on Thursday, July 23rd. Deutsche Bank lifted their price objective on shares of HCA Healthcare from $132.00 to $150.00 in a research note on Thursday, July 23rd. Finally, Piper Sandler lifted their price objective on shares of HCA Healthcare from $132.00 to $138.00 and gave the company a “neutral” rating in a research note on Thursday, July 23rd. One research analyst has rated the stock with a sell rating, three have given a hold rating and fifteen have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $146.72.
Shares of HCA opened at $126.64 on Friday. HCA Healthcare has a 12 month low of $58.38 and a 12 month high of $151.97. The firm’s 50 day moving average is $103.78 and its 200-day moving average is $114.34. The stock has a market capitalization of $42.76 billion, a PE ratio of 13.06, a P/E/G ratio of 1.11 and a beta of 1.30. The company has a current ratio of 1.09, a quick ratio of 0.95 and a debt-to-equity ratio of 54.19.
Large investors have recently modified their holdings of the company. Cutler Group LP lifted its holdings in shares of HCA Healthcare by 102.1% during the first quarter. Cutler Group LP now owns 300 shares of the company’s stock worth $26,000 after purchasing an additional 14,400 shares during the period. City Holding Co. lifted its holdings in shares of HCA Healthcare by 903.2% during the first quarter. City Holding Co. now owns 311 shares of the company’s stock worth $28,000 after purchasing an additional 280 shares during the period. Bessemer Group Inc. lifted its holdings in shares of HCA Healthcare by 57.8% during the first quarter. Bessemer Group Inc. now owns 363 shares of the company’s stock worth $33,000 after purchasing an additional 133 shares during the period. Solstein Capital LLC acquired a new position in shares of HCA Healthcare during the first quarter worth $36,000. Finally, Patriot Financial Group Insurance Agency LLC lifted its holdings in shares of HCA Healthcare by 60.8% during the first quarter. Patriot Financial Group Insurance Agency LLC now owns 534 shares of the company’s stock worth $48,000 after purchasing an additional 202 shares during the period. Institutional investors own 68.68% of the company’s stock.
In other HCA Healthcare news, insider Jon M. Foster sold 24,220 shares of the firm’s stock in a transaction that occurred on Wednesday, May 6th. The shares were sold at an average price of $100.19, for a total value of $2,426,601.80. Following the sale, the insider now owns 49,212 shares in the company, valued at $4,930,550.28. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.80% of the company’s stock.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Featured Article: What is a blue-chip stock?
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.